Focusing on the intervention and management of cognitive impairment in schizophrenia
10.3760/cma.j.cn113661-20240722-00247
- VernacularTitle:关注精神分裂症认知功能损害的干预与管理
- Author:
Sha LIU
1
;
Hong DENG
;
Xin YU
;
Chuan SHI
;
Zhening LIU
;
Dengtang LIU
;
Tianhong ZHANG
;
Zheng LU
;
Xiaobai LI
;
Chengcheng PU
Author Information
1. 山西医科大学第一医院精神卫生科 精神障碍人工智能辅助诊疗山西省重点实验室，太原 030001
- Publication Type:Journal Article
- Keywords:
Schizophrenia;
Cognitive impairment;
Treatment;
Guidance interpretation
- From:
Chinese Journal of Psychiatry
2024;57(12):801-807
- CountryChina
- Language:Chinese
-
Abstract:
Cognitive impairment is one of the core features of schizophrenia and severely affects the prognosis of the disorder. Improving cognitive impairment is of great significance for alleviating symptoms, preventing relapses, enhancing the quality of life, and reducing the social burden in patients with schizophrenia. Based on the "Guidelines for the Assessment of Cognitive Impairment in Schizophrenia" published by the European Psychiatric Association in 2022, the article focuses on the intervention and management of cognitive impairment in schizophrenia patients following a systematic assessment, while also considering the specific context of practice in China. This paper reviews recent progress in cognitive impairment interventions for schizophrenia, providing clinical guidance across three key aspects: pharmacotherapy, physical therapy, and psychotherapy. Other interventions are also discussed. Additionally, it addresses the existing challenges and unresolved issues, aiming to provide a basis for decision-making in the current treatment of cognitive impairment in schizophrenia.
